Evidence map›Paper›PMID 41731451›Full record

ArticleBMC public health2026

Barriers to the diagnosis and treatment of tuberculosis in Abidjan, Côte d'Ivoire: a qualitative study.

Noelle A Benzekri, Eric Komena, Antoine Tohbi, Patrice Gousse, Antoine Jaquet, Raoul Moh, Timothée Ouassa, Souleymane Sidibé, Olivier Marcy, Eugène Messou and 1 more

Abstract read
In one paragraph

Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Noelle A BenzekriDepartment of Medicine, Division of Allergy and Infectious Diseases, The University of Washington, Seattle, WA, USA. benzekri@uw.edu.
Eric KomenaPAC-CI Research Program, Abidjan, Côte d'Ivoire.
Antoine TohbiCePReF, Abidjan, Côte d'Ivoire.
Patrice GousseCePReF, Abidjan, Côte d'Ivoire.
Antoine JaquetNational Institute for Health and Medical Research (INSERM) UMR 1219, Research Institute for Sustainable Development (IRD) EMR 271, Bordeaux Population Health Centre, University of Bordeaux, Bordeaux, France.
Raoul MohPAC-CI Research Program, Abidjan, Côte d'Ivoire.
Timothée OuassaCEDRES, Abidjan, Côte d'Ivoire.
Souleymane SidibéProgramme National de Lutte contre la Tuberculose, Ministère de la Santé, Abidjan, Côte d'Ivoire.
Olivier Marcy *National Institute for Health and Medical Research (INSERM) UMR 1219, Research Institute for Sustainable Development (IRD) EMR 271, Bordeaux Population Health Centre, University of Bordeaux, Bordeaux, France.
Eugène Messou *CePReF, Abidjan, Côte d'Ivoire.
IeDEA West Africa Collaboration

Funding

WADA (West Africa Database on Antiretroviral Therapy) CollaborationU01AI069919 · NIAID · UNIVERSITY OF BORDEAUX II · PI Didier Koumavi Ekouevi, Antoine Jaquet · 2006 to 2026
$29.9M
NIAID NIH HHS U01 AI069919NIH HHS U01AI069919
6 · The paper itself

Abstract

backgroundTuberculosis (TB) remains a leading cause of morbidity and mortality in West Africa. An understanding of the barriers to prompt diagnosis and treatment of TB is critical in order to develop strategies to improve TB outcomes.

methodsWe conducted a qualitative sub-study within the TB-Sentinel Research Network of IeDEA at the CePReF clinic in Abidjan, Côte d’Ivoire. Individuals [Formula: see text]18 years of age who had received treatment for pulmonary TB within the preceding 12 months were interviewed. Qualitative data collection and analysis were guided by the Grounded Theory approach.

resultsInterviews were conducted with 40 participants (median age 35 [IQR 25–46] years), including 19 (47.5%) women and 9 (22.5%) people living with HIV (PLHIV). Participants experienced a substantial delay between symptom onset and TB diagnosis despite the presence of active TB symptoms and persistent care seeking. They sought care a median of 3 [IQR 2–5] times before TB testing and experienced a median diagnostic delay of 4 [IQR 3–6] months between symptom onset and TB diagnosis. The patient care pathway consisted of three distinct phases: the care-seeking phase, the diagnosis phase, and the treatment phase. Seven categories emerged across the three phases, each representing a potential barrier to the diagnosis and treatment of TB: (1) delayed TB diagnosis (sub-categories: prolonged care-seeking, repeated expenditures, and turning to sorcery), (2) fear of TB, (3) TB-associated stigma (sub-category: equating TB with HIV), (4) financial distress, (5) food insecurity, (6) enduring isolation (sub-categories: psychological distress and social setbacks), and (7) adherence anxiety.

conclusionsTo our knowledge, this is the first study to explore barriers to the diagnosis and treatment of TB in Côte d’Ivoire. Throughout each phase of the care pathway, individuals suffering from TB disease must continuously persevere in order to overcome enormous barriers. There is a need for strategies to alleviate their burden, to improve the early recognition and diagnosis of TB, and to address TB-associated stigma. Research to enhance community-based diagnostic testing, and the development and implementation of psychological support and social protection strategies, should be prioritized.

Indexed as

Health Services AccessibilityPatient Acceptance of Health CareTuberculosis, PulmonaryAdultCote d'IvoireDelayed DiagnosisFemaleHIV InfectionsHumansInterviews as TopicMaleMiddle AgedQualitative ResearchSocial StigmaTreatment DelayAdherenceCôte d’IvoireDiagnostic delayFood insecurityGrounded theoryHIVMental healthQualitative researchSorceryStigmaTraditional medicineTuberculosisWest Africa

Identifiers

PMID41731451
PMCPMC13036978

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.